The Efficacy of Tetracyclines in Prion Infection
Author Information
Author(s): De Luigi Ada, Colombo Laura, Diomede Luisa, Capobianco Raffaella, Mangieri Michela, Miccolo Claudia, Limido Lucia, Forloni Gianluigi, Tagliavini Fabrizio, Salmona Mario
Primary Institution: Istituto di Ricerche Farmacologiche “Mario Negri”, Milano, Italy
Hypothesis
Tetracyclines might interact with PrPSc and interfere with PrP amyloid formation.
Conclusion
Tetracyclines can prolong survival in hamsters infected with prion disease and may have therapeutic potential for humans.
Supporting Evidence
- A single dose of doxycycline increased median survival by 64%.
- Minocycline increased median survival by 81%.
- Doxycycline increased median survival by 35% when administered after subcutaneous infection.
- Intracerebroventricular infusion of tetracyclines showed increased survival in symptomatic animals.
Takeaway
Tetracyclines, a type of antibiotic, can help sick hamsters live longer when they have a brain disease caused by prions.
Methodology
Hamsters were infected with the 263K scrapie strain and treated with tetracyclines to assess survival rates.
Potential Biases
The small sample size may limit the statistical power of the findings.
Limitations
The study results are based on animal models and not formal clinical trials.
Participant Demographics
Male Golden Syrian hamsters, 6–8 weeks old.
Statistical Information
P-Value
0.004
Confidence Interval
95% CI for hazard ratios provided in the results.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website